Rapid Reduction in Donor-Specific Anti-Human Leukocyte Antigen Antibodies and Reversal of Antibody-Mediated Rejection With Bortezomib in Pediatric Heart Transplant Patients

BACKGROUND: High titer donor-specific antibodies (DSA) and positive crossmatch in cardiac transplant recipients is associated with increased mortality from antibody-mediated rejection (AMR). Although treatment to reduce antihuman leukocyte antigen antibodies using plasmapheresis, intravenous immunog...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Morrow, William Robert, Frazier, Elizabeth A., Mahle, William T., Harville, Terry O., Pye, Sherry E., Knecht, Kenneth R., Howard, Emily L., Smith, R. Neal, Saylors, Robert L., Garcia, Xiomara, Jaquiss, Robert D.B., Woodle, E. Steve
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3730122/
https://ncbi.nlm.nih.gov/pubmed/22179403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e31823f7eea
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki